Balancing access to BPaLM regimens and risk of resistance.
Van Rie A., Walker T., de Jong B., Rupasinghe P., Rivière E., Dartois V., Sonnenkalb L., Machado D., Gagneux S., Supply P., Dreyer V., Niemann S., Goig G., Meehan C., Tagliani E., Cirillo DM.
Tuberculosis Omics Research Consortium, Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp 2000, Belgium.